Birgit Edlich

698 total citations
10 papers, 504 citations indexed

About

Birgit Edlich is a scholar working on Oncology, Immunology and Surgery. According to data from OpenAlex, Birgit Edlich has authored 10 papers receiving a total of 504 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 4 papers in Immunology and 3 papers in Surgery. Recurrent topics in Birgit Edlich's work include Immune Cell Function and Interaction (4 papers), Bladder and Urothelial Cancer Treatments (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Birgit Edlich is often cited by papers focused on Immune Cell Function and Interaction (4 papers), Bladder and Urothelial Cancer Treatments (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Birgit Edlich collaborates with scholars based in Germany, United States and France. Birgit Edlich's co-authors include Barbara Rehermann, Golo Ahlenstiel, Yaron Rotman, Jordan J. Feld, T. Jake Liang, Mazen Noureddin, Theo Heller, Jay H. Hoofnagle, Christopher Koh and Marc G. Ghany and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and Hepatology.

In The Last Decade

Birgit Edlich

10 papers receiving 501 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Birgit Edlich Germany 6 325 255 200 70 61 10 504
Hiroyoshi Doi Japan 10 166 0.5× 206 0.8× 189 0.9× 99 1.4× 22 0.4× 19 429
Fareed Rahman Germany 8 104 0.3× 215 0.8× 207 1.0× 58 0.8× 38 0.6× 10 527
E. Sanz‐de‐Villalobos Spain 11 170 0.5× 245 1.0× 194 1.0× 91 1.3× 6 0.1× 17 396
Consuelo Comar Italy 5 134 0.4× 341 1.3× 232 1.2× 35 0.5× 11 0.2× 7 468
Hideko Nuriya Japan 11 163 0.5× 151 0.6× 177 0.9× 36 0.5× 8 0.1× 14 423
Kim Kreefft Netherlands 10 240 0.7× 245 1.0× 224 1.1× 19 0.3× 7 0.1× 13 468
Christine Benz Germany 11 118 0.4× 214 0.8× 356 1.8× 139 2.0× 75 1.2× 14 569
Krystle A. Lang Kuhs United States 10 60 0.2× 95 0.4× 118 0.6× 56 0.8× 18 0.3× 17 245
Daniel Shu United States 6 143 0.4× 50 0.2× 98 0.5× 107 1.5× 21 0.3× 15 319
Michiel C. Mommersteeg Netherlands 8 62 0.2× 167 0.7× 163 0.8× 32 0.5× 57 0.9× 15 412

Countries citing papers authored by Birgit Edlich

Since Specialization
Citations

This map shows the geographic impact of Birgit Edlich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Birgit Edlich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Birgit Edlich more than expected).

Fields of papers citing papers by Birgit Edlich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Birgit Edlich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Birgit Edlich. The network helps show where Birgit Edlich may publish in the future.

Co-authorship network of co-authors of Birgit Edlich

This figure shows the co-authorship network connecting the top 25 collaborators of Birgit Edlich. A scholar is included among the top collaborators of Birgit Edlich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Birgit Edlich. Birgit Edlich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
2.
Tufman, Amanda, Joachim von Pawel, Achim Rittmeyer, et al.. (2017). Metronomic treatment of advanced non-small-cell lung cancer with daily oral vinorelbine – a Phase I trial. OncoTargets and Therapy. Volume 10. 1081–1089. 17 indexed citations
3.
Heers, Hendrik, Patrick de Geeter, Peter J. Goebell, et al.. (2017). Vinflunine in the Τreatment of Upper Tract Urothelial Carcinoma – Subgroup Analysis of an Observational Study. Anticancer Research. 37(11). 6437–6442. 4 indexed citations
5.
Hegele, Axel, et al.. (2015). Response to vinflunine treatment after prior platinum-based chemotherapy in patients with advanced urothelial carcinoma independent of primary tumor location.. Journal of Clinical Oncology. 33(15_suppl). e15536–e15536. 1 indexed citations
6.
Wit, Maike de, Patrick de Geeter, Luca Galli, et al.. (2015). 2640 Vinflunine maintenance treatment following first-line therapy of advanced urothelial carcinoma - results from the JASiMA trial. European Journal of Cancer. 51. S527–S527. 5 indexed citations
7.
Ahlenstiel, Golo, Birgit Edlich, Leah J. Hogdal, et al.. (2011). Early Changes in Natural Killer Cell Function Indicate Virologic Response to Interferon Therapy for Hepatitis C. Gastroenterology. 141(4). 1231–1239.e2. 126 indexed citations
8.
Edlich, Birgit, Golo Ahlenstiel, Aintzane Zabaleta, et al.. (2011). Early Changes in Interferon Signaling Define Natural Killer Cell Response and Refractoriness to Interferon–Based Therapy of Hepatitis C Patients. Hepatology. 55(1). 39–48. 90 indexed citations
9.
Edlich, Birgit, Leah J. Hogdal, Barbara Rehermann, & Sven‐Erik Behrens. (2010). Dendritic cells transfected with Her2 antigen-encoding RNA replicons cross-prime CD8 T cells and protect mice against tumor challenge. Vaccine. 28(49). 7764–7773. 4 indexed citations
10.
Ahlenstiel, Golo, Christopher Koh, Birgit Edlich, et al.. (2009). Natural Killer Cells Are Polarized Toward Cytotoxicity in Chronic Hepatitis C in an Interferon-Alfa–Dependent Manner. Gastroenterology. 138(1). 325–335.e2. 209 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026